首页> 外文期刊>Nature >alpha-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling
【24h】

alpha-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling

机译:alpha-Klotho是FGF23激素信号转导的非酶分子支架

获取原文
获取原文并翻译 | 示例
       

摘要

The ageing suppressor alpha-klotho binds to the fibroblast growth factor receptor (FGFR). This commits FGFR to respond to FGF23, a key hormone in the regulation of mineral ion and vitamin D homeostasis. The role and mechanism of this co-receptor are unknown. Here we present the atomic structure of a 1:1:1 ternary complex that consists of the shed extracellular domain of alpha-klotho, the FGFR1c ligand-binding domain, and FGF23. In this complex, alpha-klotho simultaneously tethers FGFR1c by its D3 domain and FGF23 by its C-terminal tail, thus implementing FGF23-FGFR1c proximity and conferring stability. Dimerization of the stabilized ternary complexes and receptor activation remain dependent on the binding of heparan sulfate, a mandatory cofactor of paracrine FGF signalling. The structure of alpha-klotho is incompatible with its purported glycosidase activity. Thus, shed alpha-klotho functions as an on-demand non-enzymatic scaffold protein that promotes FGF23 signalling.
机译:衰老抑制剂α-klotho与成纤维细胞生长因子受体(FGFR)结合。这使FGFR对FGF23作出反应,FGF23是调节矿物质离子和维生素D稳态的关键激素。该共同受体的作用和机制尚不清楚。在这里,我们介绍了一个1:1:1三元复合物的原子结构,该复合物由α-klotho的脱落细胞外结构域,FGFR1c配体结合结构域和FGF23组成。在这种复合物中,α-klotho同时通过其D3结构域束缚FGFR1c,并通过其C末端尾部束缚FGF23,从而实现FGF23-FGFR1c接近并赋予稳定性。稳定的三元复合物的二聚化和受体活化仍然取决于硫酸乙酰肝素的结合,硫酸乙酰肝素是旁分泌FGF信号传导的必需辅助因子。 α-klotho的结构与其声称的糖苷酶活性不相容。因此,脱落的α-klotho用作促进FGF23信号转导的按需非酶支架蛋白。

著录项

  • 来源
    《Nature》 |2018年第7689期|461-466|共6页
  • 作者单位

    Wenzhou Med Univ, Sch Pharmaceut Sci, Chem Biol Res Ctr, Wenzhou 325035, Zhejiang, Peoples R China|NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA;

    NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA;

    NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA;

    Wenzhou Med Univ, Sch Pharmaceut Sci, Chem Biol Res Ctr, Wenzhou 325035, Zhejiang, Peoples R China|NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA;

    New York Struct Biol Ctr, New York, NY 10027 USA;

    Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA|Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA|Univ Texas Southwestern Med Ctr Dallas, Charles & Jane Pak Ctr Mineral Metab & Clin Res, Dallas, TX 75390 USA;

    Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA|Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA|Univ Texas Southwestern Med Ctr Dallas, Charles & Jane Pak Ctr Mineral Metab & Clin Res, Dallas, TX 75390 USA;

    Wenzhou Med Univ, Sch Pharmaceut Sci, Chem Biol Res Ctr, Wenzhou 325035, Zhejiang, Peoples R China;

    Wenzhou Med Univ, Sch Pharmaceut Sci, Chem Biol Res Ctr, Wenzhou 325035, Zhejiang, Peoples R China;

    NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:51:29

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号